182 related articles for article (PubMed ID: 8765421)
1. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential.
Papayannopoulou T
Cancer Chemother Pharmacol; 1996; 38 Suppl():S69-73. PubMed ID: 8765421
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
3. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ
Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234
[TBL] [Abstract][Full Text] [Related]
4. Role for C-MPL and its ligand thrombopoietin in early hematopoiesis.
Katayama N; Itoh R; Kato T; Sugawara T; Mahmud N; Ohishi K; Masuya M; Aoki M; Minami N; Miyazaki H; Shiku H
Leuk Lymphoma; 1997 Dec; 28(1-2):51-6. PubMed ID: 9498703
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
7. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
Skotnicki AB; Jabłoński MJ
Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
9. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
10. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
Alexander WS
Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
[TBL] [Abstract][Full Text] [Related]
12. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
Griesshammer M; Bangerter M; Schrezenmeier H
Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
[TBL] [Abstract][Full Text] [Related]
13. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.
Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P
Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874
[TBL] [Abstract][Full Text] [Related]
14. [Biology of thrombopoietin and its receptors].
Robak T
Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
[TBL] [Abstract][Full Text] [Related]
15. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
Kaushansky K
Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
[TBL] [Abstract][Full Text] [Related]
17. The role of the MPL receptor in myeloproliferative disorders.
Kaushansky K
Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
[TBL] [Abstract][Full Text] [Related]
18. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
[TBL] [Abstract][Full Text] [Related]
20. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
Lok S; Foster DC
Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
